RankingsPricing
  1. JP-listed companies
  2. Fuji Pharma Co.,Ltd.
  3. Financials
  4. Cash from investing

Fuji Pharma Co.,Ltd.【JP:4554】

Market cap
¥47.4B
P/E ratio
12.2x
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndCash from investing (Million JPY)YoY (%)
Sep 30, 2025-4,219+154.46%
Sep 30, 2024-1,658-68.36%
Sep 30, 2023-5,240-53.51%
Sep 30, 2022-11,271+380.64%
Sep 30, 2021-2,345-10.36%
Sep 30, 2020-2,616-78.24%
Sep 30, 2019-12,024+1020.60%
Sep 30, 2018-1,073-30.05%
Sep 30, 2017-1,534-53.78%
Sep 30, 2016-3,319-432.23%
Sep 30, 2015999-150.58%
Sep 30, 2014-1,975

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)